Clin2
NCT07286812Possibly a fitNot yet recruiting

Screening for early memory issues in community adults

Alzheimer Disease

Part of Brain & nervous system, Mental health clinical trials.

This study uses digital tools and blood tests to check for early signs of memory problems in healthy older adults living in the community. The goal is to find people who might be at risk for conditions like Alzheimer's disease before symptoms get worse.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
50 years and older
Study type
Observational

Who can take part

  • You are 50 years old or older.
  • You have lived in your current community for at least one year and have medical records there.
  • You have never been told you have mild cognitive impairment, dementia, or Alzheimer's disease.
  • You have never taken medications for dementia (like donepezil or memantine).
  • You are willing to take part in the study, and you and your family speak Chinese well enough to communicate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests

This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.

Greenfield Park, Quebec
NCT07272811Recruiting
Computer memory testing for early Alzheimer's signs

This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.

Milan, Italy
NCT04575337Recruiting
Biomarker study to help detect Alzheimer’s early

This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.

Beijing, Beijing Municipality
NCT07401849Not yet recruiting
Blood test for early Alzheimer's detection in primary care

This study looks at whether a simple blood test can help doctors detect Alzheimer's disease early, even before symptoms are clear. It is designed for people who are worried about their memory or thinking and want to find out more.

NCT06529744Recruiting
Using blood tests to better diagnose early dementia

This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.

North York, Ontario
NCT07521722Not yet recruiting
Blood Tests for Alzheimer's Risk in Healthy Adults

This research study tests new blood tests that may detect early signs of Alzheimer's disease in people who currently have normal thinking and memory. By participating, you help researchers understand who might be at risk and develop better ways to predict the disease early.

Barcelona

Hear when a new Alzheimer Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.